Research Study to Evaluate LOTRONEX in Severe IBS-D: Analysis of Current Clinical Practice Environment.

Trial Profile

Research Study to Evaluate LOTRONEX in Severe IBS-D: Analysis of Current Clinical Practice Environment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2013

At a glance

  • Drugs Alosetron (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Acronyms RELIANCE
  • Sponsors Prometheus Laboratories
  • Most Recent Events

    • 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top